This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, while suppressing immune responses to vaccines. The reduction of T cell epitopes and introduction of Treg epitopes (like Tregitopes) for protein therapeutics, and the reverse process for vaccines, will be discussed and illustrated in case studies.
What: Immunogenicity and Tolerance Seminar
When: Monday, October 24th, 2016
Where: Hilton Apollolaan
Cost: €75.00 (covers the food/venue – this is a not-for-profit event)
Platine and EpiVax have created a one-of-a-kind forum for discussion on current approaches in immunogenicity and tolerance induction, with a focus on biologics and vaccines. Co-organizers will include Immuno Valley, Lyon Biopole and MabDesign. The small size of this forum fosters a personal environment where participants engage each other and have the opportunity to connect with the presenters.